RPG Life Sciences completes API Business Transfer to RPG Active Pharma

M&A / JV 15 Aug 2026 · Completed· ✓ Verified

RPG Life Sciences executed and completed a BTA to transfer its API business division to RPG Active Pharma Limited, a fellow group entity. The transfer involved the hiving-off of active pharmaceutical ingredient manufacturing, asset and liability operations. This is a restructuring within the RPG pharmaceutical conglomerate designed to consolidate API capabilities under a dedicated subsidiary. No acquisition price or consideration amount was publicly disclosed in the filing; typical of intra-group transfers, these are often effected at book value or via inter-corporate debt. Regulatory approval (if required under MCA / stock exchange rules for related-party transactions) is not explicitly…

Why it mattersIntra-group pharma reorganisations triggering Schedule VI asset transfer & continuity of employee obligations; review if any contract consents / intellectual property licences were implicit in the BTA structure.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals